Yasuo Takashima

8PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineMedical infection agents (incl. prions)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 24, 2021
Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.

Yasuo Takashima, Atsushi Kawaguchi, Junya Fukai

|May 23, 2020
GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL.

Yasuo Takashima, Momoko Hamano, Junya Fukai

|Feb 29, 2020
Metabolome Analysis Reveals Excessive Glycolysis via PI3K/AKT/mTOR and RAS/MAPK Signaling in Methotrexate-Resistant Primary CNS Lymphoma-Derived Cells.

Yasuo Takashima, Azusa Hayano, Ryuya Yamanaka

|Feb 27, 2020
miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.

Yasuo Takashima, Atsushi Kawaguchi, Yasuo Iwadate

|Oct 27, 2019
Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma.

Yasuo Takashima, Atsushi Kawaguchi, Ryuya Yamanaka

|Sep 13, 2019
Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells.

Yasuo Takashima, Takeshi Yoshimura, Yuichiro Kano

Pageof 2

Frequent Collaborators

4 joint publications

Yasuo Takashima

2 joint publications

Junya Fukai